91 related articles for article (PubMed ID: 11049207)
1. Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver.
Kakizaki S; Takagi H; Ichikawa T; Abe T; Yamada T; Suzuki K; Kojima A; Takayama H; Takezawa J; Nagamine T; Mori M
Biol Trace Elem Res; 2000 Feb; 73(2):151-62. PubMed ID: 11049207
[TBL] [Abstract][Full Text] [Related]
2. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
[TBL] [Abstract][Full Text] [Related]
3. [A prospective study on histological and serological changes after interferon alpha-2b treatment in patients with chronic hepatitis B infection].
Lang Z; Zhao C; Xu D
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):145-7. PubMed ID: 11517899
[TBL] [Abstract][Full Text] [Related]
4. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
[TBL] [Abstract][Full Text] [Related]
5. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
[TBL] [Abstract][Full Text] [Related]
6. Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon.
Ikawa H; Hayashi Y; Ninomiya T; Yano Y; Nakaji M; Nagano H; Seo Y; Kumon Y; Yoon S; Kasuga M; Itoh H; Ohbayashi C
Hum Pathol; 2001 Sep; 32(9):910-7. PubMed ID: 11567219
[TBL] [Abstract][Full Text] [Related]
7. [Serologic response against hepatitis C virus as a predictive factor to the treatment with interferon].
Garrido A; Lepe JA; Guerrero FJ; Palomo S
Enferm Infecc Microbiol Clin; 2000 Dec; 18(10):512-5. PubMed ID: 11198002
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum concentrations of human hepatocyte growth factor during interferon therapy for chronic hepatitis C.
Moriyama M; Matsumura H; Watanabe A; Oshiro S; Aoki H; Shimizu T; Nakai K; Yamagami H; Kaneko M; Shioda A; Tanaka N; Arakawa Y
Intervirology; 2005; 48(4):223-9. PubMed ID: 15920346
[TBL] [Abstract][Full Text] [Related]
9. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
Mathai J; Shimoda K; Banner BF; Mori M; Bonkovsky HL; Barnard GF
J Interferon Cytokine Res; 1999 Sep; 19(9):1011-8. PubMed ID: 10505743
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha-induced changes in metallothionein expression in liver biopsies from patients with chronic hepatitis C.
Nagamine T; Suzuki K; Kondo T; Nakazato K; Kakizaki S; Takagi H; Nakajima K
Can J Gastroenterol; 2005 Aug; 19(8):481-6. PubMed ID: 16107899
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Sherman KE; Sjogren M; Creager RL; Damiano MA; Freeman S; Lewey S; Davis D; Root S; Weber FL; Ishak KG; Goodman ZD
Hepatology; 1998 Apr; 27(4):1128-35. PubMed ID: 9537454
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
Everson GT; Jensen DM; Craig JR; van Leeuwen DJ; Bain VG; Ehrinpreis MN; Albert D; Joh T; Witt K
Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
[TBL] [Abstract][Full Text] [Related]
14. The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.
Cammà C; Giunta M; Linea C; Pagliaro L
J Hepatol; 1997 Jun; 26(6):1187-99. PubMed ID: 9210603
[TBL] [Abstract][Full Text] [Related]
15. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
[TBL] [Abstract][Full Text] [Related]
16. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
[TBL] [Abstract][Full Text] [Related]
17. Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.
Serejo F; Costa A; Oliveira AG; Ramalho F; Batista A; De Moura MC
Dig Dis Sci; 2001 Aug; 46(8):1684-9. PubMed ID: 11508668
[TBL] [Abstract][Full Text] [Related]
18. Serum total bile acid level as a sensitive indicator of hepatic histological improvement in chronic hepatitis C patients responding to interferon treatment.
Shima T; Tada H; Morimoto M; Nakagawa Y; Obata H; Sasaki T; Park H; Nakajo S; Nakashima T; Okanoue T; Kashima K
J Gastroenterol Hepatol; 2000 Mar; 15(3):294-9. PubMed ID: 10764031
[TBL] [Abstract][Full Text] [Related]
19. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
[TBL] [Abstract][Full Text] [Related]
20. Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.
Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Erer B; Gaziev D; Piga A; Di Gregorio F; Romeo MA; Mangiagli A; Petrelli E; Muretto P
Bone Marrow Transplant; 1997 Nov; 20(9):767-72. PubMed ID: 9384479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
